Preclinical Disease or Risk Factor? Alzheimer’s Disease as a Case Study of Changing Conceptualizations of Disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical Disease or Risk Factor? Alzheimer’s Disease as a Case Study of Changing Conceptualizations of Disease
Authors
Keywords
-
Journal
JOURNAL OF MEDICINE AND PHILOSOPHY
Volume 48, Issue 4, Pages 322-334
Publisher
Oxford University Press (OUP)
Online
2023-05-19
DOI
10.1093/jmp/jhad009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential Consequences of Changing Disease Classifications
- (2020) Jenny A. Doust et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vascular dysfunction—The disregarded partner of Alzheimer's disease
- (2019) Melanie D. Sweeney et al. Alzheimers & Dementia
- Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer’s disease
- (2019) James A R Nicoll et al. BRAIN
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- On the reconceptualization of Alzheimer’s disease
- (2018) Maartje H. N. Schermer et al. BIOETHICS
- Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment
- (2017) Steffen Wolfsgruber et al. JOURNAL OF ALZHEIMERS DISEASE
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
- (2016) Bruno Dubois et al. Alzheimers & Dementia
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
- (2014) Reisa Sperling et al. NEURON
- Small Tumors as Risk Factors not Disease
- (2014) Peter H. Schwartz PHILOSOPHY OF SCIENCE
- Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020
- (2013) Harald Hampel et al. BIOCHEMICAL PHARMACOLOGY
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Preclinical Alzheimer disease—the challenges ahead
- (2012) Reisa A. Sperling et al. Nature Reviews Neurology
- Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Clifford R. Jack et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
- (2011) Clifford R. Jack et al. ANNALS OF NEUROLOGY
- New lexicon and criteria for the diagnosis of Alzheimer's disease
- (2011) Giorgio Giaccone et al. LANCET NEUROLOGY
- Predicting MCI outcome with clinically available MRI and CSF biomarkers
- (2011) D. Heister et al. NEUROLOGY
- Desktop Medicine
- (2010) Jason Karlawish JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Age, Neuropathology, and Dementia
- (2009) George M. Savva et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More